BeStock  
Stocks › Biotechnology › ARDX

Ardelyx ARDX

US equityMarket cap rank #3341Biotechnology
$2.99 −$0.07 (-2.29%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $2.99 0.00%
Open$3.01
Prev close$3.06
Day range$2.95 – $3.08
Volume6.20M
Market cap$751.60M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$127.66M+15.7% YoY
Operating profit$4.02M-13.8% YoY
Net profit-$737,000.00+23.9% YoY
Diluted EPS$0.00
Free cash flow$2.17M+938.8% YoY
Operating cash flow$2.17M

Revenue, last 8 quarters

$116.1MDec '24$74.1MMar '25$97.7MJun '25$110.3MSep '25$125.2MDec '25$94.5MMar '26$120.9MJun '26$127.7MSep '26

Net profit, last 8 quarters

$4.6MDec '24$-41.1MMar '25$-19.1MJun '25$-969.0KSep '25$-407.0KDec '25$-37.6MMar '26$-16.7MJun '26$-737.0KSep '26

Diluted EPS by quarter

0.02Dec '24-0.17Mar '25-0.08Jun '250.00Sep '250.00Dec '25-0.15Mar '26-0.07Jun '260.00Sep '26

Free cash flow by quarter

$9.2MDec '24$-38.8MMar '25$-26.0MJun '25$209.0KSep '25$20.6MDec '25$-32.3MMar '26$-6.4MJun '26$2.2MSep '26

Annual revenue

$7.6MFY20$10.1MFY21$52.2MFY22$124.5MFY23$333.6MFY24$407.3MFY25

Profitability & balance sheet

Gross margin94.5%
Operating margin-7.7%
Net margin-11.8%
Return on equity-34.9%
Return on assets-10.3%
Return on invested capital-9.9%
Current ratio3.45
Liabilities / assets72.1%
Cash & investments$285.34M
Total debt$254.76M
Net cash (debt)$30.58M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Product sales, net$125.46M 98.3%
  • Other revenues$2.20M 1.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $127.66M $120.88M $94.47M $407.32M $125.22M
Total Operating Revenue $127.66M $120.88M $94.47M $407.32M $125.22M
Cost of Revenue $4.54M $5.76M $4.81M $39.54M $10.85M
Gross Profit $123.12M $115.12M $89.66M $367.78M $114.37M
Operating Expense $119.09M $127.54M $122.46M $408.76M $109.27M
Selling and Admin Expenses $93.89M $101.44M $102.27M $337.23M $86.41M
Research & Development $25.20M $26.10M $20.19M $71.53M $22.86M
Operating Profit $4.02M -$12.43M -$32.79M -$40.98M $5.10M
Net Non-Operating Interest Income (Expense) -$7.38M -$6.22M -$6.92M -$28.40M -$7.58M
Non-Operating Interest Expense $7.38M $6.22M $6.92M $28.40M $7.58M
Other Income (Expense) $2.71M $2.04M $2.11M $8.75M $2.08M
Other Non-Operating Income (Expenses) $2.71M $2.04M $2.11M $8.75M $2.08M
Pretax Profit -$647,000.00 -$16.61M -$37.60M -$60.63M -$400,000.00
Tax $90,000.00 $110,000.00 $8,000.00 $969,000.00 $7,000.00
Net Profit -$737,000.00 -$16.72M -$37.61M -$61.60M -$407,000.00
Profit from Continuing Operations -$737,000.00 -$16.72M -$37.61M -$61.60M -$407,000.00
Net Income to Parent Company -$737,000.00 -$16.72M -$37.61M -$61.60M -$407,000.00
Net Income to Common Stockholders -$737,000.00 -$16.72M -$37.61M -$61.60M -$407,000.00
Basic EPS $0.00 -$0.07 -$0.15 -$0.26 $0.00
Diluted EPS $0.00 -$0.07 -$0.15 -$0.26 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $587.53M $575.89M $504.51M $501.60M $501.60M
Total Current Assets $441.39M $441.93M $381.87M $382.32M $382.32M
Cash and Cash Equivalents & Short-Term Investments $285.34M $281.83M $238.07M $264.69M $264.69M
-Cash and Cash Equivalents $46.32M $97.19M $31.21M $68.00M $68.00M
-Short Term Investments $239.02M $184.64M $206.87M $196.69M $196.69M
Receivables $93.44M $100.35M $82.84M $71.85M $71.85M
-Accounts Receivable $93.44M $100.35M $82.84M $71.85M $71.85M
Prepaid Assets $17.16M $14.70M $14.64M $14.48M $14.48M
Inventory $24.44M $25.86M $22.75M $17.74M $17.74M
Other Current Assets $21.01M $19.19M $23.58M $13.57M $13.57M
Total Non-Current Assets $146.14M $133.97M $122.64M $119.29M $119.29M
Net PPE $5.26M $5.85M $6.44M $6.98M $6.98M
-Gross PPE $5.26M $5.85M $6.44M $9.63M $9.63M
Other Non-Current Assets $140.88M $119.63M $111.96M $112.31M $112.31M
Total Liabilities $423.48M $426.88M $355.89M $334.66M $334.66M
Total Current Liabilities $127.81M $132.22M $109.57M $88.61M $88.61M
Payables $33.66M $38.41M $28.20M $19.24M $19.24M
-Accounts Payable $33.66M $38.41M $28.20M $19.24M $19.24M
Current Accrued Expenses $69.48M $70.96M $67.23M $40.23M $40.23M
Short-Term Debt and Capital Lease Obligation $1.58M $1.55M $1.51M $1.48M $1.48M
-Current Capital Lease Obligation $1.58M $1.55M $1.51M $1.48M $1.48M
Current Deferred Liabilities $5.50M $6.74M $3.25M $1.21M $1.21M
Total Non-Current Liabilities $295.67M $294.66M $246.32M $246.05M $246.05M
Long Term Debt and Capital Lease Obligation $254.76M $254.65M $206.75M $206.48M $206.48M
-Long Term Debt $252.36M $251.82M $203.52M $202.83M $202.83M
-Long Term Capital Lease Obligation $2.40M $2.82M $3.24M $3.64M $3.64M
Non-Current Deferred Liabilities $40.91M $40.02M $39.56M $39.58M $39.58M
Total Equity $164.05M $149.01M $148.62M $166.95M $166.95M
Stockholders' Equity $164.05M $149.01M $148.62M $166.95M $166.95M
Capital Stock $25,000.00 $25,000.00 $25,000.00 $24,000.00 $24,000.00
-Common Stock $25,000.00 $25,000.00 $25,000.00 $24,000.00 $24,000.00
Additional Paid-In Capital $1.17B $1.15B $1.13B $1.11B $1.11B
Retained Earnings -$1.00B -$1.00B -$984.54M -$946.94M -$946.94M
Gains/Losses Not Affecting Retained Earnings -$483,000.00 -$193,000.00 -$124,000.00 $198,000.00 $198,000.00
Non-Current Prepaid Assets – $8.49M $4.24M – –
-Accumulated Depreciation – – – -$2.65M -$2.65M
Other Current Liabilities – – – $7.35M $7.35M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $2.17M -$6.40M -$32.24M -$42.48M $20.95M
Net cash flow from continuing operations $2.17M -$6.40M -$32.24M -$42.48M $20.95M
Net Income from Continuing Operations -$737,000.00 -$16.72M -$37.61M -$61.60M -$407,000.00
Depreciation & Depletion & Amortization $621,000.00 $604,000.00 $915,000.00 $3.06M $921,000.00
Other Non-Cash Items $848,000.00 $743,000.00 $678,000.00 -$1.55M $326,000.00
Change in Working Capital -$13.66M -$6.34M -$10.38M -$31.35M $7.67M
-Change in Receivables $6.91M -$17.51M -$10.99M -$14.14M $4.76M
-Change in Inventory -$18.57M -$10.96M -$4.92M -$31.92M $6.25M
-Change in Prepaid Assets $2.84M $200,000.00 -$14.40M -$2.39M -$4.95M
-Change in Payables and Accrued Expense -$3.21M $18.82M $18.26M $21.95M $7.33M
-Change in Other Current Liabilities -$388,000.00 -$380,000.00 -$373,000.00 -$1.83M -$353,000.00
-Change In Other Working Capital -$1.24M $3.49M $2.04M -$3.01M -$5.38M
Net cash flow from investing -$54.00M $22.66M -$10.00M -$8.96M $3.78M
Net Cash Flow from Continuing Investing Activities -$54.00M $22.66M -$10.00M -$8.96M $3.78M
Net PPE Purchase and Sale $0.00 -$13,000.00 -$69,000.00 -$1.49M -$361,000.00
Net Investment Purchase and Sale -$54.00M $22.67M -$9.93M -$7.47M $4.14M
Financing Cash Flow $959,000.00 $49.72M $5.44M $54.51M $557,000.00
Net Cash Flow from Continuing Financing Activities $959,000.00 $49.72M $5.44M $54.51M $557,000.00
Net Issuance Payments Of Debt $0.00 – – $48.67M $0.00
Proceeds from Stock Option Exercised $959,000.00 $1.68M $5.44M $5.84M $557,000.00
Ending Cash Balance $46.32M $97.19M $31.21M $68.00M $68.00M
Net Change in Cash -$50.87M $65.98M -$36.79M $3.07M $25.28M
Beginning Cash Balance $97.19M $31.21M $68.00M $64.93M $42.72M
Free Cash Flow $2.17M -$6.41M -$32.31M -$43.98M $20.59M
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on ARDX.

Sign in to join the discussion.

Scroll to Top